SwipeRx

Singapore, Singapore Founded: 2012 • Age: 14 yrs
Online community and B2B platform for pharmacy professionals is operated.

About SwipeRx

SwipeRx is a Healthcare company based in Singapore (Singapore) founded in 2012 by Farouk Meralli. Online community and B2B platform for pharmacy professionals is operated. SwipeRx has raised $10 million across 2 funding rounds from investors including Johnson & Johnson, Sanofi and Gates Foundation. Its chief executive, as recorded, is Farouk Meralli. Its website swiperx.com draws about 13 thousand monthly visits. SwipeRx offers products and services including SwipeRx App, CPD Education Modules, and B2B Commerce Tool. Its focus areas include HealthTech, Pharmacy IT and Professional Network. Its legal entity in India is mClinica Pte. Ltd (U73200DL2012FTC229857).

Company details

SwipeRx was founded in 2012 in Singapore as an online platform serving the pharmacy sector. An community space is maintained where professionals access news and industry information. Connections among colleagues are facilitated through networking features. A B2B commerce tool is provided, enabling procurement of affordable and readily available medicines for business operations.

Key Metrics
  • Total Equity Funding
    $10M (USD)

    in 2 rounds

  • Latest Funding Round
    $10M (USD), Series B

    Feb 2023

  • Investors

Products & Services of SwipeRx

SwipeRx offers a comprehensive portfolio of products and services, including SwipeRx App, CPD Education Modules, and B2B Commerce Tool.

SwipeRx App
Digital Platform

App for pharmacy professionals to connect, learn, and conduct B2B commerce.

CPD Education Modules
Education Tool

Modules providing accredited professional development for pharmacists.

B2B Commerce Tool
Ecommerce Service

Tool for pharmacies to purchase medicines and supplies efficiently.

Apps and channels of SwipeRx

SwipeRx publishes 2 mobile apps with over 100K+ downloads.

SwipeRx
Google Play Social Everyone Free
Developer: mClinica
View on Google Play
SwipeRx
App Store Social Networking 17+
Developer: mClinica Pte. Ltd.
View on App Store

Funding Insights of SwipeRx

SwipeRx has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10M
  • Total Rounds 2
  • Last Round Series B β€” $10M
  • Investors Count 6

All 2 funding rounds of SwipeRx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2023$10MSeries B–Sanofi, Cercano Management
–
Jun 2022Debt – Conventional––
Valuation history

6 investors in total: 6 institutional.

Investors in SwipeRx

SwipeRx has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson, Sanofi and Gates Foundation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on seed and late stage investments
sig-asiavc.comHong Kong, China
Venture capital firm investing in multiple sectors
patamar.comBengaluru, India
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas.
1973sanofi.comParis, France
Provides investment advisory services to ultra-high-net-worth individuals and families.
2021cercanolp.comBellevue, United States
Healthcare solutions are provided by Johnson & Johnson globally.
1886jnj.comNew Brunswick, United States
Charitable foundation investments on poverty reduction and healthcare
2000gatesfoundation.orgSeattle, United States
Premium access

Investor details for SwipeRx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Mclinica Health Solutions Private Limited (SwipeRx)

Mclinica Health Solutions Private Limited is the primary company behind SwipeRx. The board of Mclinica Health Solutions Private Limited currently have 2 directors; the longest-serving is Farouk Meralli, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Farouk Meralli
DIN 05149808
Director12 Jan 201214 yrs 9 moMclinica Health Solutions Private Limited
Feroze Rehman
DIN 05148814
Director12 Jan 201214 yrs 9 moMclinica Health Solutions Private Limited

People of SwipeRx

1 people are tracked at SwipeRx (1 in leadership).

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for SwipeRx

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of SwipeRx

3 dated milestones of SwipeRx across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded SwipeRx is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B, of $10.0M.

Web traffic of SwipeRx

The website of SwipeRx (swiperx.com) receives about 12.5K visits a month.

  • Monthly visits
    12.5K

    ▼ 23% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Swiperx

Premium access

Complete news archive for SwipeRx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SwipeRx

SwipeRx was founded in 2012 and raised its 1st funding round 10 years after it was founded.

SwipeRx is headquartered in Singapore, Singapore.

Farouk Meralli is the CEO of SwipeRx, as recorded in our data. They have also founded this company.

SwipeRx is a funded company, having raised a total of $10M across 2 funding rounds to date.

SwipeRx was founded in 2012 in Singapore as an online platform serving the pharmacy sector. An community space is maintained where professionals access news and industry information. Connections among colleagues are facilitated through networking features. A B2B commerce tool is provided, enabling procurement of affordable and readily available medicines for business operations.

SwipeRx offers SwipeRx App, CPD Education Modules, and B2B Commerce Tool.

SwipeRx has 6 investors. Key investors include Johnson & Johnson, Sanofi, Gates Foundation, Cercano Management, and SIG Venture Capital.

SwipeRx operates through Mclinica Health Solutions Private Limited.

The legal entities of SwipeRx currently have 2 directors, including Farouk Meralli, Feroze Rehman.

Yes. SwipeRx publishes SwipeRx and 1 more app, with over 100,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available